May 8 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2020 Mar 31, 2019 Mar 31, 2021 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 4.61 4.67 4.50 2.10
(-1.3 pct) (+6.5 pct) (-2.4 pct) (-7.8 pct)
Operating 608 mln 581 mln 450 mln 220 mln
(+4.7 pct) (+27.4 pct) (-26.1 pct) (-31.5 pct)
Recurring 616 mln 596 mln 450 mln 220 mln
(+3.3 pct) (+25.0 pct) (-27.0 pct) (-31.5 pct)
Net 398 mln 385 mln 300 mln 140 mln
(+3.3 pct) (+38.9 pct) (-24.7 pct) (-36.7 pct)
EPS 97.09 yen 98.57 yen 71.74 yen 33.48 yen
Ann Div 15.00 yen 15.00 yen 15.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 15.00 yen 15.00 yen 15.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T